St. Paul's Hospital
Vancouver, British Columbia, V6Z 1Y6, Canada
NCT Number: NCT02336919
Participants will be recruited during their hospitalization for either heart attack or unstable angina and will be randomly assigned to either a text message program (Txt2Prevent) or usual care. They will be texted for the first 60-days after discharge. Texts will include topics regarding self-management and discharge protocols such as reminders to make an appointment with their general practitioner or to refill medication prescriptions. After 60 days, the two groups will be compared for hospital readmission rates, quality of life, medication adherence, and self-management.
Looking for future studies?
Notify Me19 year and older
All sexes
Interventional
Not applicable
Vancouver, British Columbia, V6Z 1Y6, Canada
Cardiovascular disease is one of the leading causes for hospitalization and death in Canada. Being discharged is often a challenging and overwhelming time. Sometimes patients are readmitted to the hospital shortly in the months following their discharge. Some of these readmissions are due to information transfer being poor or insufficient.
Previous studies have looked at whether text messaging can be a simple, cost-effective way to help patients. Therefore, we wish to investigate the effectiveness of using text messaging to help heart patients after they are discharged from the hospital.
The goal of this study is to determine the impact of a pilot text-messaging intervention program (Txt2Prevent) that supports coronary syndrome (heart attack and unstable angina) patients for 60 days after their hospital discharge. The program will include information about follow-up care, medication use, and healthy lifestyle behaviours. The texts will be sent at relevant times during the patients' recovery.
The primary objective is compare self-management between the usual care patients versus the Txt2prevent patients. We hypothesize that the Txt2Prevent group will have better self-management than the usual care group.
The secondary objective is compare medication adherence, and health-related quality of life as well as readmission and mortality rates between the two patient groups. We hypothesize that the Txt2Prevent group will have better outcomes for these variables.
The study population is acute coronary syndrome patients at St. Paul's hospital who are discharged. Participants will be randomly assigned to one of two groups-a usual care group and the usual care plus the Txt2Prevent text messaging program group. All participants will undergo a baseline assessment that includes:
After 60 days, participants will be contacted again to perform a follow up assessment that includes:
In both the baseline and follow-up assessments, information may be obtained from the patient's medical chart or records (e.g. medical history) or self-report.
After the intervention, some intervention participants will be contacted to complete a semi-structured interview about their experiences with the Txt2Prevent program.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A 60-day text messaging program called Txt2Prevent (see description in the arm description).
Time frame: Pre- and post-study period (0 and 60 days)
Time frame: Post-study period (60 days)
Time frame: Pre- and post-study period (0 and 60 days)
Time frame: Assessed at the end of the study (day 60)
Time frame: Assessed at the end of the study (day 60)
Simon Fraser University
Other
The Use of Text Messaging to Improve the Hospital-community Transition and Prevent Readmission in Patients With Cardiovascular Disease (Txt2Prevent)
Acronym: Txt2Prevent
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01609842
Acute Coronary Syndrome, Cardiovascular Disease
Aurora, Colorado, United States
View Trial DetailsNCT00768274
Acute Coronary Syndrome, Arterial Occlusive Diseases
Dallas, Texas, United States
View Trial DetailsNCT01164371
Acute Coronary Syndrome, Angina Pectoris
View Trial DetailsNCT00531362
Acute Coronary Syndrome, Arterial Occlusive Diseases
Dublin, Ireland
View Trial Details